Neumega and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is reported as a side effect among people who take Neumega (oprelvekin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neupogen, and have Thrombocytopenia.

The phase IV clinical study analyzes which people have Fluid retention when taking Neumega. It is created by eHealthMe based on reports of 818 people who have side effects when taking Neumega from the FDA, and is updated regularly.

What is Neumega?

Neumega has active ingredients of oprelvekin. eHealthMe is studying from 822 Neumega users. Check the latest studies of Neumega.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,700 drugs and 2,447 conditions by eHealthMe. Check the latest studies of Fluid retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 13, 2026

818 people reported to have side effects when taking Neumega.
Among them, 36 people (4.4%) have Fluid retention.

Among these 36 people:

How long have people been on Neumega when they have Fluid retention? *

What is the gender of people who have Fluid retention when taking Neumega? *

female: 51.43 %
male: 48.57 %

What is the age of people who have Fluid retention when taking Neumega? *

What are other drugs people take besides Neumega? *

What are other side effects people have besides Fluid retention? *

Pericardial Effusion (fluid around the heart): 8 people, 22.22%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 22.22%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 5 people, 13.89%
Cardiac Failure Congestive: 5 people, 13.89%
Pain In Extremity: 5 people, 13.89%
Nausea (feeling of having an urge to vomit): 5 people, 13.89%
Salivary Hypersecretion (excess saliva secretion): 5 people, 13.89%
Depression: 5 people, 13.89%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 5 people, 13.89%
Eye Irritation: 5 people, 13.89%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 6 people, 16.67%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Neumega and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neumega:

Neumega (822 reports)

Fluid retention treatments and more:

Fluid retention (79,660 reports)

Browse all side effects of Neumega:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid retention:

Fluid retention (1,700 drugs)

Browse all the conditions that are associated with Fluid retention:

Fluid retention (2,447 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oprelvekin (the active ingredients of Neumega) and Neumega (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.